- Research Group Home Page:
After completing his BsC+MSc in Biology from the University of Lisbon (Portugal) Filipe started his PhD in the University of Lyon (France). During his PhD in Patrick Mehlen’s laboratory at the Centre de Recherche en Cancerologie de Lyon Filipe found a new functional ligand for the Amyloid Precursor Protein (APP), a key protein in Alzheimer’s disease.
With his PhD in hand Filipe then moved to Mike Olson’s laboratory at the CRUK Beatson Institute in Glasgow (Scotland) to work in the role of F-actin dynamics in intestinal stem biology as well as colorectal cancer initiation and progression.
Filipe joined Winton Group in 2013 and since then he has been interested in understanding and modelling colorectal cancer initiation in mouse models using chemical mutagenesis.
- Work address:
- Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.E-pub date: 1 Jan 2021Journal name: Nucl Med Biol
MRI of Bladder Cancer: Local and Nodal Staging.E-pub date: 1 Sep 2020Journal name: J Magn Reson Imaging
Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.E-pub date: 31 Aug 2020Journal name: Eur Radiol